AI MARKET SCANNING

Liquidia Corporation

📅 Next Catalyst: Nov 03, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP +1.43%
MAX GAP RECORD +11.33%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LQDA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN)
-5.01%
May 11, 2026 Earnings Release 2026-05-11 (BEFORE OPEN)
+4.26%
Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN)
-6.92%
Nov 03, 2025 Earnings Release 2025-11-03 (BEFORE OPEN)
+11.33%
Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN)
+8.02%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.00%
Mar 19, 2025 Earnings Release 2025-03-19 (BEFORE OPEN)
-2.44%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.7%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LQDA

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 949m +0.00%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗